Efficacy of ertugliflozin (ERTU) on hospitalisation for heart failure (HHF) across the spectrum of pre-trial ejection fraction (EF): post hoc analyses of VERTIS CV

被引：0

作者：

Pandey, A. ^{[1
]}

Kolkailah, A. A. ^{[1
]}

Cosentino, F. ^{[2
,3
]}

Cannon, C. P. ^{[4
]}

Frederich, R. ^{[5
]}

Cherney, D. Z. I. ^{[6
]}

Dagogo-Jack, S. ^{[7
]}

Pratley, R. E. ^{[8
]}

Cater, N. B. ^{[9
]}

Gantz, I. ^{[10
]}

Mancuso, J. P. ^{[11
]}

McGuire, D. K. ^{[1
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA

[2] Karolinska Inst, Unit Cardiol, Stockholm, Sweden

[3] Karolinska Univ Hosp, Stockholm, Sweden

[4] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA USA

[5] Pfizer Inc, Collegeville, PA USA

[6] Univ Toronto, Toronto, ON, Canada

[7] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA

[8] AdventHlth Translat Res Inst, Orlando, FL USA

[9] Pfizer Inc, New York, NY USA

[10] Merck Co Inc, Kenilworth, NJ USA

[11] Pfizer Inc, Groton, CT USA

来源：

DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

252

引用

页码：S133 / S133

页数：1

共 10 条

[1] Efficacy of ertugliflozin on hospitalisation for heart failure across the distribution of pre-trial ejection fraction: post hoc analyses of the VERTIS CV trial
Pandey, A.
Kolkailah, A. A.
Cosentino, F.
Cannon, C. P.
Frederich, R.
Cherney, D. Z., I
Dagogo-Jack, S.
Pratley, R. E.
Cater, N. B.
Gantz, I
Mancuso, J. P.
McGuire, D. K.
[J]. EUROPEAN HEART JOURNAL, 2022, 43 : 962 - 962
[2] Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial
Pandey, Ambarish
Kolkailah, Ahmed A.
Cosentino, Francesco
Cannon, Christopher P.
Frederich, Robert C.
Cherney, David Z., I
Dagogo-Jack, Samuel
Pratley, Richard E.
Cater, Nilo B.
Gantz, Ira
Mancuso, James P.
McGuire, Darren K.
[J]. EUROPEAN HEART JOURNAL, 2023, 44 (48) : 5163 - 5166
[3] Mediation analyses of the effect of ertugliflozin on hospitalisation for heart failure in patients with type 2 diabetes and atherosclerotic cardiovascular disease from the VERTIS CV trial
Segar, M. W.
Pandey, A.
Cherney, D. Z. I.
Cannon, C. P.
Cosentino, F.
Dagogo-Jack, S.
Pratley, R. E.
Shih, W. J.
Frederich, R.
Cater, N. B.
Maldonado, M.
Liu, J.
Liu, C.
Pong, A.
McGuire, D. K.
[J]. EUROPEAN HEART JOURNAL, 2021, 42 : 2649 - 2649
[4] EFFICACY OF ERTUGLIFLOZIN ON HEART FAILURE HOSPITALIZATION AND HF DEATH ACROSS THE WATCH-DM RISK SCORE: A SECONDARY ANALYSIS OF THE VERTIS CV TRIAL
Segar, Matthew
McGuire, Darren K.
Frederich, Robert
Cherney, David Z. I.
Cannon, Christopher P.
Cosentino, Francesco
Dagogo-Jack, Samuel
Pratley, Richard
Cater, Nilo B.
Maldonado, Mario
Emir, Birol
Jeng, Darren
Shi, Harry
Pandey, Ambarish
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1445 - 1445
[5] Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction A Post Hoc Analysis of the DAPA-HF Trial
Butt, Jawad H.
Dewan, Pooja
Merkely, Bela
Belohlavek, Jan
Drozdz, Jaroslaw
Kitakaze, Masafumi
Inzucchi, Silvio E.
Kosiborod, Mikhail N.
Martinez, Felipe A.
Tereshchenko, Sergey
Ponikowski, Piotr
Bengtsson, Olof
Lindholm, Daniel
Langkilde, Anna Maria
Schou, Morten
Sjostrand, Mikaela
Solomon, Scott D.
Sabatine, Marc S.
Chiang, Chern-En
Docherty, Kieran F.
Jhund, Pardeep S.
Kober, Lars
McMurray, John J. V.
[J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) : 820 - +
[6] Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: a post hoc analysis of the DAPA-HF trial
Butt, J. H.
Dewan, P.
Docherty, K.
Inzucchi, S.
Ponikowski, P.
Martinez, F.
Bengtsson, O.
Sjostrand, M.
Solomon, S. D.
Sabatine, M.
Kosiborod, M.
Langkilde, A. M.
Jhund, P. S.
Kober, L.
Mcmurray, J. J. V.
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 138 - 139
[7] Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction A Post Hoc Analysis of the EMPEROR-Preserved Trial
Butler, Javed
Usman, Muhammad Shariq
Filippatos, Gerasimos
Ferreira, Joao Pedro
Boehm, Michael
Brueckmann, Martina
Januzzi, James L.
Kaul, Sanjay
Pina, Ileana L.
Ponikowski, Piotr
Senni, Michele
Sumin, Mikhail
Verma, Subodh
Zaremba-Pechmann, Liliana
Pocock, Stuart J.
Packer, Milton
Anker, Stefan
[J]. JAMA CARDIOLOGY, 2023, 8 (07) : 640 - 649
[8] Efficacy and safety of sacubitril/valsartan according to frailty in heart failure with preserved ejection fraction: a post hoc analysis of the PARAGON-HF trial
Butt, J. H.
Dewan, P.
Kober, L.
Jhund, P. S.
Solomon, S. D.
McMurray, J. J. V.
[J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1052 - 1052
[9] Remote patient management of heart failure across the ejection fraction spectrum: a pre-specified analysis of the TIM-HF2 trial
Kerwagen, Fabian
Koehler, Kerstin
Vettorazzi, Eik
Stangl, Verena
Koehler, Magdalena
Halle, Martin
Koehler, Friedrich
Stoerk, Stefan
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (09) : 1671 - 1681
[10] Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Pre-Specified Analysis From the ADVOR Trial
Martens, Pieter
Dauw, Jeroen
Verbrugge, Frederik
Meekers, Evelyne
Damman, Kevin
Ruschitzka, Frank
Tang, Wai Hong W.
Dupont, Matthias
Mullens, Wilfried
[J]. CIRCULATION, 2022, 146 (25) : E585 - E585

← 1 →